|
MAML2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.035700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.081400E-03 |
| Normal-vs-Stage2 |
4.36179999999675E-05 |
| Normal-vs-Stage3 |
2.43209999999383E-05 |
| Normal-vs-Stage4 |
2.789500E-04 |
| Stage1-vs-Stage2 |
3.943500E-02 |
| Stage1-vs-Stage3 |
7.084400E-02 |
| Stage1-vs-Stage4 |
1.430350E-01 |
| Stage2-vs-Stage3 |
3.374400E-01 |
| Stage2-vs-Stage4 |
4.378200E-01 |
| Stage3-vs-Stage4 |
9.607600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.352400E-04 |
| Normal-vs-AfricanAmerican |
6.204200E-01 |
| Normal-vs-Asian |
5.090300E-02 |
| Caucasian-vs-AfricanAmerican |
9.090400E-02 |
| Caucasian-vs-Asian |
5.506400E-01 |
| AfricanAmerican-vs-Asian |
3.711400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3953000000041E-05 |
| Normal-vs-Female |
1.198380E-03 |
| Male-vs-Female |
2.152800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.162000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.761050E-04 |
| Normal-vs-Age(61-80Yrs) |
2.68219999999264E-06 |
| Normal-vs-Age(81-100Yrs) |
1.636110E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.695700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.351600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.968990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.999400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.969600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.678390E-02 |
| Classical-VS-Follicular |
3.8317127248888E-12 |
| Classical-VS-Other |
1.333010E-01 |
| Classical-VS-Normal |
4.015900E-02 |
| Tall-VS-Follicular |
7.441800E-03 |
| Tall-VS-Other |
3.735400E-01 |
| Tall-VS-Normal |
7.218300E-04 |
| Follicular-VS-Other |
5.268400E-01 |
| Follicular-VS-Normal |
7.65820740156187E-12 |
| Other-VS-Normal |
1.068270E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83050000005058E-06 |
| Normal-vs-N1 |
2.958200E-03 |
| N0-vs-N1 |
3.581400E-01 |
|
|
